Zealand Pharma (CPH: ZEAL) stock: the official figures
Zealand Pharma (ZEALAND PHARMA A/S) is listed on Nasdaq Copenhagen under the ticker ZEAL and belongs to the health care sector. In fiscal 2025 it reported revenue of DKK 9,215m and a net profit of DKK 6,455m, according to the annual accounts it filed with the regulator.
Identifiers for Zealand Pharma: ISIN DK0060257814 · LEI 549300ITBB1ULBL4CZ12.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | DKK 9,215m | DKK 62.7m | +14,598.9% |
| Operating profit | DKK 6,959m | −DKK 1,272m | — |
| Net profit | DKK 6,455m | −DKK 1,079m | — |
| Earnings per share | DKK 91.56 | −DKK 16.24 | — |
| Operating margin | 75.5% | −2,029.3% | +2,104.9 pts |
| Net margin | 70.0% | −1,720.9% | +1,790.9 pts |
| Total assets | DKK 15,949m | DKK 9,506m | +67.8% |
| Equity | DKK 14,831m | DKK 8,617m | +72.1% |
| Cash | DKK 4,577m | DKK 480.3m | +852.8% |
| Operating cash flow | DKK 6,532m | −DKK 930.8m | — |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
7 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|---|
| 2025 | DKK 9,215m | DKK 6,959m | DKK 6,455m | DKK 91.56 | Annual report |
| 2024 | DKK 62.7m | −DKK 1,272m | −DKK 1,079m | −DKK 16.24 | Annual report |
| 2023 | DKK 342.8m | −DKK 572.2m | −DKK 703.7m | −DKK 12.44 | Annual report |
| 2022 | DKK 104.0m | −DKK 837.2m | −DKK 1,202m | −DKK 26.02 | Annual report |
| 2021 | DKK 108.5m | −DKK 784.3m | −DKK 1,018m | −DKK 23.75 | — |
| 2020 | DKK 353.3m | −DKK 792.4m | −DKK 846.7m | −DKK 22.07 | Annual report |
| 2019 | DKK 41.3m | −DKK 587.9m | −DKK 571.5m | −DKK 16.91 | — |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Zealand Pharma.
Frequently asked questions about Zealand Pharma
- How much did Zealand Pharma earn in fiscal 2025?
- Zealand Pharma reported a net profit of DKK 6,455m for fiscal 2025, on revenue of DKK 9,215m. The year before it reported a net loss of DKK 1,079m.
- What are the earnings per share of Zealand Pharma?
- They were DKK 91.56 in fiscal 2025, compared with −DKK 16.24 the year before.
- Where is Zealand Pharma listed?
- Zealand Pharma is listed on Nasdaq Copenhagen under the ticker ZEAL and belongs to the health care sector.
- What is the ISIN of Zealand Pharma?
- The ISIN of Zealand Pharma is DK0060257814, the international code that identifies its shares. Its LEI, the legal entity identifier, is 549300ITBB1ULBL4CZ12.
- Where do the figures for Zealand Pharma come from?
- From the report Zealand Pharma files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the report Zealand Pharma files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.